MOLECULAR MODELING OF THE INCLUSION COMPLEXES BETWEEN BETA-CYCLODEXTRIN AND (R)/(S)-METHYLPHENOBARBITONE AND ITS APPLICATION TO HPLC

被引:19
作者
DURHAM, DG
LIANG, HX
机构
[1] School of Pharmacy, Robert Gordon University, Aberdeen
关键词
HPLC; REVERSE-PHASE ADDITIVE; BETA-CYCLODEXTRIN; METHYLPHENOBARBITONE; MOLECULAR MECHANICS; COMPLEX STABILITY; CHIRAL SEPARATION;
D O I
10.1002/chir.530060405
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecular modelling of beta-cyclodextrin and optimisation of its potential energy suggests that a favoured conformation is that distorted from a symmetrical torus. The inclusion of water molecules into the torus cavity simulates the increased stability in an aqueous solvent. Complexes of beta-cyclodextrin with (R)- and (S)-enantiomers of methylphenobarbitone have been modelled and energetically optimised by the application of molecular mechanics. The simulations suggests that the guest molecules adopt an orientation in which the phenyl ring is projected into the torus cavity, with in each case the plane of the ring parallel to a longer axis of the distorted torus and slightly displaced from the axis through the torus cavity. It is suggested that the asymmetry in the macrocyclic ring contributes to chiral recognition as a result of additional discriminatory binding to the barbiturate ring residue of each enantiomer, which occupy different 3D geometries. The enantiomers form complexes of different minimum potential energies. The resulting difference in complex stability can be related to the behaviour of beta-cyclodextrin, as a mobile phase additive in reverse-phase HPLC to effect chiral separation of rac-methylphenobarbitone during chromatography. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 24 条
[1]  
ALLENMARK SG, 1988, CHROMATOGRAPHIC ENAN, P134
[2]   MOLECULAR MODELING OF BETA-CYCLODEXTRIN COMPLEXES WITH NOOTROPIC DRUGS [J].
AMATO, ME ;
DJEDAINI, F ;
PAPPALARDO, GC ;
PERLY, B ;
SCARLATA, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (12) :1157-1161
[3]  
Bender ML, 1978, CYCLODEXTRIN CHEM, P2
[4]   CYCLODEXTRIN CHIRAL STATIONARY PHASES FOR LIQUID-CHROMATOGRAPHIC SEPARATIONS OF DRUG STEREOISOMERS [J].
BERTHOD, A ;
JIN, HL ;
BEESLEY, TE ;
DUNCAN, JD ;
ARMSTRONG, DW .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (02) :123-130
[5]   HPLC AND H-1-NMR STUDY OF CHIRAL RECOGNITION IN SOME THROMBOXANE ANTAGONISTS INDUCED BY BETA-CYCLODEXTRIN [J].
CASY, AF ;
COOPER, AD ;
JEFFERIES, TM ;
GASKELL, RM ;
GREATBANKS, D ;
PICKFORD, R .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (10-12) :787-792
[6]   COMPUTATIONAL CHEMISTRY APPLIED TO THE DESIGN OF CHIRAL STATIONARY PHASES FOR ENANTIOMERIC SEPARATION [J].
DAPPEN, R ;
KARFUNKEL, HR ;
LEUSEN, FJJ .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (02) :181-193
[7]  
DUCHENE D, 1987, CYCLODEXTRINS THEIR, P107
[8]  
DUCHENE D, 1990, 5TH INT S CYCL PAR, P99
[9]  
DUCHENE D, 1987, CYCLODEXTRINS THEIR, P200
[10]  
Durham D. G., 1992, Journal of Pharmacy and Pharmacology, V44, P1078